CMPX Financials
Compass Therapeutics Inc. - Financial statements & key metrics
Stock Price
$2.29
Market Cap
$367.38M
P/E Ratio
-6.4
EPS
$-0.45
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-49.38M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$140.40M
Total Liabilities
$15.17M
Shareholders Equity
-
Cash & Equivalents
$43.48M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-44.85M
CapEx
-
Free Cash Flow
-
Profitability Metrics
00
ROE
-37.8%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CMPX revenue?
View CMPX's income statement for detailed revenue data.
Is CMPX profitable?
CMPX reported a loss of $49.38M in the most recent quarter.
What is CMPX market cap?
CMPX has a market capitalization of $367.38M, making it a small-cap stock.
Does CMPX have debt?
View CMPX's balance sheet for debt information.
What is CMPX cash flow?
Cash flow data is available in the full financial statements.